|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 17/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/519 | (2006.01) |
| (11) | Number of the document | 3856341 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20722936.0 |
| Date of filing the European patent application | 2020-04-10 | |
| (97) | Date of publication of the European application | 2021-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation | 2023-12-27 |
| (86) | Number | PCT/US2020/027724 |
| Date | 2020-04-10 |
| (87) | Number | WO 2020/210669 |
| Date | 2020-10-15 |
| (30) | Number | Date | Country code |
| 201962833527 P | 2019-04-12 | US | |
| 201962844575 P | 2019-05-07 | US | |
| 202062990269 P | 2020-03-16 | US |
| (72) |
WAETZIG, Joshua, D. , US
MAR, Brenton , US
HEINRICH, Brian , US
WILKIE, Gordon , US
MACEACHERN, Lauren , CA
|
| (73) |
Blueprint Medicines Corporation ,
45 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | (S)-1-(4-fluorfenil)-1-(2-(4-(6-(1-metil-1H-pirazol-4-il)pirolo[2,1-F] [1,2,4]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amino kristalinės formos ir gamybos būdai |
| CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING |
| Payment date | Validity (years) | Amount | |
| 2025-03-05 | 6 | 139.00 EUR |
| 2026-04-10 |